My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 437

    1.

    The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.

    Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, Fowler S; Diabetes Prevention Program Research Group.

    Ann Intern Med. 2005 Apr 19;142(8):611-9.PMID: 15838067 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations]

    Flórez H.

    Invest Clin. 1997 Mar;38(1):39-52. Review. Spanish. PMID: 9235072 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.

    Harden KA, Cowan PA, Velasquez-Mieyer P, Patton SB.

    J Am Acad Nurse Pract. 2007 Jul;19(7):368-77.PMID: 17680902 [PubMed - indexed for MEDLINE]Related articles

    4.

    Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.

    Ratner R, Goldberg R, Haffner S, Marcovina S, Orchard T, Fowler S, Temprosa M; Diabetes Prevention Program Research Group.

    Diabetes Care. 2005 Apr;28(4):888-94.PMID: 15793191 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

    Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group.

    N Engl J Med. 2002 Feb 7;346(6):393-403.PMID: 11832527 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention: the Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group.

    Goldberg RB, Temprosa M, Haffner S, Orchard TJ, Ratner RE, Fowler SE, Mather K, Marcovina S, Saudek C, Matulik MJ, Price D; Diabetes Prevention Program Research Group.

    Diabetes Care. 2009 Apr;32(4):726-32. Epub 2009 Jan 26.PMID: 19171717 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.

    Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE; Diabetes Prevention Program Research Group.

    Ann Intern Med. 2005 Mar 1;142(5):323-32.PMID: 15738451 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.

    Eddy DM, Schlessinger L, Kahn R.

    Ann Intern Med. 2005 Aug 16;143(4):251-64.PMID: 16103469 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes.

    Diabetes Prevention Program Research Group, Crandall J, Schade D, Ma Y, Fujimoto WY, Barrett-Connor E, Fowler S, Dagogo-Jack S, Andres R.

    J Gerontol A Biol Sci Med Sci. 2006 Oct;61(10):1075-81.PMID: 17077202 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention.

    Fu JF, Liang L, Zou CC, Hong F, Wang CL, Wang XM, Zhao ZY.

    Int J Obes (Lond). 2007 Jan;31(1):15-22. Epub 2006 Sep 5.PMID: 16953257 [PubMed - indexed for MEDLINE]Related articles

    11.

    The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes.

    [No authors listed]

    Diabetes Care. 1999 Apr;22(4):623-34. Erratum in: Diabetes Care 1999 Aug;22(8):1389. PMID: 10189543 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions.

    Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, Fowler S, Kahn SE; Diabetes Prevention Program Research Group.

    J Clin Endocrinol Metab. 2008 Dec;93(12):4774-9. Epub 2008 Sep 30.PMID: 18826999 [PubMed - indexed for MEDLINE]Related articles

    13.

    Relationship of body size and shape to the development of diabetes in the diabetes prevention program.

    [No authors listed]

    Obesity (Silver Spring). 2006 Nov;14(11):2107-17.PMID: 17135629 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program.

    Perreault L, Ma Y, Dagogo-Jack S, Horton E, Marrero D, Crandall J, Barrett-Connor E; Diabetes Prevention Program.

    Diabetes Care. 2008 Jul;31(7):1416-21. Epub 2008 Mar 20.PMID: 18356403 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Alcohol consumption and diabetes risk in the Diabetes Prevention Program.

    Crandall JP, Polsky S, Howard AA, Perreault L, Bray GA, Barrett-Connor E, Brown-Friday J, Whittington T, Foo S, Ma Y, Edelstein SL; Diabetes Prevention Program Research Group.

    Am J Clin Nutr. 2009 Sep;90(3):595-601. Epub 2009 Jul 29.PMID: 19640960 [PubMed - indexed for MEDLINE]Related articles

    16.

    Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.

    Roberts VL, Stewart J, Issa M, Lake B, Melis R.

    Clin Ther. 2005 Oct;27(10):1535-47.PMID: 16330290 [PubMed - indexed for MEDLINE]Related articles

    17.

    Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial.

    Davey Smith G, Bracha Y, Svendsen KH, Neaton JD, Haffner SM, Kuller LH; Multiple Risk Factor Intervention Trial Research Group.

    Ann Intern Med. 2005 Mar 1;142(5):313-22.PMID: 15738450 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group.

    [No authors listed]

    Diabetes Care. 2000 Nov;23(11):1619-29.PMID: 11092283 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome.

    Glueck CJ, Papanna R, Wang P, Goldenberg N, Sieve-Smith L.

    Metabolism. 2003 Jul;52(7):908-15.PMID: 12870169 [PubMed - indexed for MEDLINE]Related articles

    20.

    Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom.

    Palmer AJ, Roze S, Valentine WJ, Spinas GA, Shaw JE, Zimmet PZ.

    Clin Ther. 2004 Feb;26(2):304-21.PMID: 15038953 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity